Antigen export in M. tuberculosis evasion of CD4 T cells
结核分枝杆菌逃避 CD4 T 细胞的抗原输出
基本信息
- 批准号:9318402
- 负责人:
- 金额:$ 72.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-20 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntigen PresentationAntigen Presentation PathwayAntigen TargetingAntigensAntimycobacterial AgentsAttenuatedAutophagocytosisBacteriaBacterial AntigensBypassCD4 Positive T LymphocytesCell membraneCellsClinical TrialsDataDendritic CellsDevelopmentDisease ProgressionDynaminEffectivenessExtracellular SpaceGenerationsGenus MycobacteriumGoalsHistocompatibility Antigens Class IIImmune systemImmunodominant AntigensImpairmentInfectionInfection ControlKinesinLungManuscriptsMeasuresMediator of activation proteinMembraneMicrobeMicrotubulesMolecularMolecular MotorsMycobacterium tuberculosisPathway interactionsPhagosomesPharmaceutical PreparationsPharmacologyPhaseProblem SolvingProteinsPublicationsReportingRoleSecondary toShunt DeviceSiteT cell responseT-LymphocyteTestingTimeTuberculosisTuberculosis VaccinesVaccinationVaccine DesignVaccinesVesicleVesicle Transport PathwayWorkadaptive immunityimprovedin vivolymph nodesmacrophagenovelpathogenpreventresponsevaccine development
项目摘要
A major obstacle to developing an efficacious TB vaccine is illustrated by the results of a recent clinical trial in
which the vaccine induced polyfunctional T cell responses, yet it did not prevent TB. This obstacle is also
illustrated in animal models, as existing TB vaccines induce T cell responses, but have only modest effects on
bacterial burdens. These results suggest that antigen-specific T cells are generated by infection or vaccination
and they can be activated by ex vivo restimulation, but they are not activated effectively at the site of infection.
The long term objective of this project is to guide development of efficacious TB vaccines by: 1) characterizing
a major mechanism that limits the ability of antigen-specific CD4 T cells to recognize M. tuberculosis-infected
cells and become activated at the site of infection; and 2) developing solutions that overcome or bypass that
mechanism. We have discovered that M. tuberculosis-infected cells activate CD4 T cells poorly because
multiple secreted bacterial antigens are shunted away from the MHC class II antigen processing and
presentation pathway and are exported from the infected cells. This novel mechanism, which we term antigen
export, involves intracellular vesicular transport, and requires the microtubule-directed molecular motor,
kinesin-2. When we deplete M. tuberculosis-infected cells of kinesin 2 and thus block antigen export, we find
increased MHC class II antigen presentation and CD4 T cell activation by infected cells, resulting in improved
control of intracellular M. tuberculosis. This indicates that CD4 T cells have the potential to exert effective
antimycobacterial activity, but their activation is limited by poor antigen presentation by infected cells, and poor
antigen presentation is secondary to antigen export. This project will extend these findings and characterize
the other cellular mechanisms required for antigen export, including budding of antigen export vesicles (AEV)
from phagosomes, intracellular targeting of AEV, and fusion of AEV membranes with the plasma membrane for
release of antigens to the extracellular space. Our goal is to identify host molecules that can be targeted with
drugs to block antigen export and make antigen-specific CD4 T cells more effective in TB. To inform TB
vaccine design, we hypothesize that nonsecreted (and nonexported) antigens are more desirable than
secreted antigens in TB vaccines, since secreted antigens are exported from infected cells, making the
infected cells poor targets for recognition by CD4 T cells specific for those antigens. To test the hypothesis that
CD4 T cells directed against a nonsecreted antigen are more efficacious than those directed against a
secreted antigen, we have modified an immunodominant secreted M. tuberculosis antigen (Ag85B) so that it is
not secreted, and we will determine whether bacteria that express nonsecreted-nonexported Ag85B are better
controlled by CD4 T cells in vivo. Together, our proposed studies will guide efforts to make naturally-occurring
and vaccine-induced CD4 T cells more effective in TB, and contribute to solving the problem of global
tuberculosis.
最近一项临床试验的结果说明了开发有效结核疫苗的一个主要障碍,
疫苗诱导多功能T细胞反应,但它不能预防结核病。这一障碍也是
在动物模型中说明,因为现有的TB疫苗诱导T细胞应答,但对
细菌负荷这些结果表明,抗原特异性T细胞是通过感染或接种疫苗产生的
并且它们可以通过离体再刺激而被激活,但是它们在感染部位不能被有效地激活。
该项目的长期目标是通过以下方式指导有效结核疫苗的开发:1)表征
这是限制抗原特异性CD 4 T细胞识别M的能力的主要机制。结核病感染者
细胞并在感染部位被激活;以及2)开发克服或绕过
机制我们发现M。结核病感染的细胞激活CD 4 T细胞很差,
多种分泌的细菌抗原从MHC II类抗原加工中分流,
这些蛋白质通过递呈途径从受感染的细胞输出。我们称之为抗原的新机制
输出,涉及胞内囊泡运输,并需要微管定向分子马达,
驱动蛋白-2。当我们耗尽M。结核感染的细胞驱动蛋白2,从而阻止抗原输出,我们发现,
通过感染的细胞增加MHC II类抗原呈递和CD 4 T细胞活化,导致改善的
胞内M.结核这表明,CD 4 T细胞具有发挥有效作用的潜力。
它们具有抗分枝杆菌活性,但它们的活化受到感染细胞的抗原呈递差和抗分枝杆菌活性差的限制。
抗原呈递是抗原输出的第二步。该项目将扩展这些发现,并描述
抗原输出所需的其他细胞机制,包括抗原输出囊泡(AEV)的出芽
从吞噬体,AEV的细胞内靶向,以及AEV膜与质膜的融合,
将抗原释放到细胞外空间。我们的目标是鉴定出可以被靶向的宿主分子,
阻断抗原输出并使抗原特异性CD 4 T细胞在结核病中更有效的药物。告知结核病
在疫苗设计中,我们假设非分泌(和非输出)抗原比
结核病疫苗中的分泌抗原,因为分泌抗原是从受感染的细胞中输出的,
感染的细胞缺乏被那些抗原特异性的CD 4 T细胞识别的靶标。为了验证这个假设,
针对非分泌性抗原的CD 4 T细胞比针对非分泌性抗原的CD 4 T细胞更有效。
分泌抗原,我们已经修改了免疫显性分泌M。结核抗原(Ag 85 B),使其
不分泌,我们将确定表达非分泌非输出Ag 85 B的细菌是否更好
在体内由CD 4 T细胞控制。总之,我们提出的研究将指导努力,使自然发生的
而疫苗诱导的CD 4 T细胞对结核病更有效,有助于解决全球结核病问题。
结核
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel D. Ernst其他文献
The immunological life cycle of tuberculosis
结核病的免疫生命周期
- DOI:
10.1038/nri3259 - 发表时间:
2012-07-13 - 期刊:
- 影响因子:60.900
- 作者:
Joel D. Ernst - 通讯作者:
Joel D. Ernst
Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicana is a transient phenomenon preceding the acquisition of annexin I by the phagosome.
吞噬颗粒向墨西哥利什曼原虫寄生液泡的转移是吞噬体获得膜联蛋白 I 之前的短暂现象。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:4
- 作者:
Helen L. Collins;Ulrich E. Schaible;Joel D. Ernst;David G. Russell - 通讯作者:
David G. Russell
Editorial response: variation in clinical and immune responses to bacille Calmette-Guérin--implications for an improved tuberculosis vaccine.
编辑回应:卡介苗临床和免疫反应的变化——对改进结核病疫苗的影响。
- DOI:
10.1086/515202 - 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Joel D. Ernst - 通讯作者:
Joel D. Ernst
Antibody-Fab and -Fc features promote emMycobacterium tuberculosis/em restriction
抗体的 Fab 和 Fc 特征促进了对结核分枝杆菌的限制。
- DOI:
10.1016/j.immuni.2025.05.004 - 发表时间:
2025-06-10 - 期刊:
- 影响因子:26.300
- 作者:
Patricia S. Grace;Joshua M. Peters;Jaimie Sixsmith;Richard Lu;Edward B. Irvine;Corinne Luedeman;Brooke A. Fenderson;Andrew Vickers;Matthew D. Slein;Tanya McKitrick;Mo-Hui Wei;Richard D. Cummings;Aaron Wallace;Lisa A. Cavacini;Alok Choudhary;Megan K. Proulx;Christopher Sundling;Gunilla Källenius;Rajko Reljic;Joel D. Ernst;Galit Alter - 通讯作者:
Galit Alter
Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design
寻找并填补 T 细胞介导的结核病免疫机制中的知识空白,为疫苗设计提供信息
- DOI:
10.1038/s41577-025-01192-z - 发表时间:
2025-06-13 - 期刊:
- 影响因子:60.900
- 作者:
Emma Lefrançais;Denis Hudrisier;Olivier Neyrolles;Samuel M. Behar;Joel D. Ernst - 通讯作者:
Joel D. Ernst
Joel D. Ernst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel D. Ernst', 18)}}的其他基金
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Functional dynamics of TB granuloma architecture
结核肉芽肿结构的功能动力学
- 批准号:
10593978 - 财政年份:2022
- 资助金额:
$ 72.01万 - 项目类别:
Functional dynamics of TB granuloma architecture
结核肉芽肿结构的功能动力学
- 批准号:
10358264 - 财政年份:2022
- 资助金额:
$ 72.01万 - 项目类别:
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
宿主遗传多样性、单核吞噬细胞和结核病的结果
- 批准号:
10005738 - 财政年份:2020
- 资助金额:
$ 72.01万 - 项目类别:
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
宿主遗传多样性、单核吞噬细胞和结核病的结果
- 批准号:
10194362 - 财政年份:2020
- 资助金额:
$ 72.01万 - 项目类别:
Epitope-specific T cell activation to complement TB immunity and vaccine efficacy
表位特异性 T 细胞激活可补充结核病免疫和疫苗功效
- 批准号:
8867688 - 财政年份:2014
- 资助金额:
$ 72.01万 - 项目类别:
Initiation of the Immune Response to M. tuberculosis
对结核分枝杆菌的免疫反应的启动
- 批准号:
8678398 - 财政年份:2014
- 资助金额:
$ 72.01万 - 项目类别:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
体内结核分枝杆菌逃避 CD4 T 细胞
- 批准号:
8678383 - 财政年份:2013
- 资助金额:
$ 72.01万 - 项目类别:
相似海外基金
RNA vaccine that exerts antitumor effect via non-canonical antigen presentation pathway
通过非经典抗原呈递途径发挥抗肿瘤作用的RNA疫苗
- 批准号:
19K07782 - 财政年份:2019
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Climate change and fish disease: In vivo and in vitro studies of the modulation of the teleost antigen presentation pathway in response to thermal stress and viral infection using two different system
气候变化和鱼类疾病:使用两种不同的系统对硬骨鱼抗原呈递途径的调节响应热应激和病毒感染进行体内和体外研究
- 批准号:
469000-2014 - 财政年份:2015
- 资助金额:
$ 72.01万 - 项目类别:
Banting Postdoctoral Fellowships Tri-council
Climate change and fish disease: In vivo and in vitro studies of the modulation of the teleost antigen presentation pathway in response to thermal stress and viral infection using two different system
气候变化和鱼类疾病:使用两种不同的系统对硬骨鱼抗原呈递途径的调节响应热应激和病毒感染进行体内和体外研究
- 批准号:
469000-2014 - 财政年份:2014
- 资助金额:
$ 72.01万 - 项目类别:
Banting Postdoctoral Fellowships Tri-council
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
8652945 - 财政年份:2012
- 资助金额:
$ 72.01万 - 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
8466919 - 财政年份:2012
- 资助金额:
$ 72.01万 - 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
9054767 - 财政年份:2012
- 资助金额:
$ 72.01万 - 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
8373738 - 财政年份:2012
- 资助金额:
$ 72.01万 - 项目类别:
Investigation of the HLA class II Antigen Presentation Pathway in Estrogen Receptor Negative and Estrogen Receptor Positive Breast Carcinoma.
雌激素受体阴性和雌激素受体阳性乳腺癌中 HLA II 类抗原呈递途径的研究。
- 批准号:
186899 - 财政年份:2009
- 资助金额:
$ 72.01万 - 项目类别:
Fellowship Programs
Down regulation of antigen presentation pathway plays an important role in metastasis and progression of advanced stage of epithelial ovarian cancer.
抗原呈递途径的下调在上皮性卵巢癌晚期的转移和进展中发挥重要作用。
- 批准号:
21390449 - 财政年份:2009
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New anti-tuberculosis vaccine strategies by the use of the CD1-lipid antigen presentation pathway
利用 CD1-脂质抗原呈递途径的新抗结核疫苗策略
- 批准号:
15390317 - 财政年份:2003
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)